Why Access to Psychedelic Therapy Is Still So Limited, and What We Asked the UN to Change
Psilocybin and MDMA therapy are closer to approval than ever, yet still hard to reach. I explain why, and what my colleagues and I asked a UN expert panel to change.
Microdosing Psilocybin Is More Common Than You Think: What a National Survey Shows
About 11 million U.S. adults used psilocybin last year, and most of them microdosed at least once. I walk through what a new national survey found, what it can't tell us, and what to consider if you microdose.
